tiprankstipranks
Trending News
More News >
Jasper Therapeutics (JSPR)
NASDAQ:JSPR
US Market

Jasper Therapeutics (JSPR) Income Statement

Compare
1,057 Followers

Jasper Therapeutics Income Statement

Last quarter (Q3 2025), Jasper Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Jasper Therapeutics's net income was $-18.74M. See Jasper Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 76.24M$ 68.86M$ 51.20M$ 36.83M$ 20.68M
Depreciation and Amortization
$ 1.37M$ 1.11M$ 975.00K$ 377.00K$ 20.68M
EBITDA
$ -74.87M$ -67.75M$ -50.22M$ -36.46M$ 0.00
Operating Income
$ -76.24M$ -68.86M$ -51.20M$ -36.83M$ -20.68M
Other Income/Expenses
$ 4.97M$ 4.40M$ 13.51M$ 6.20M$ -10.99M
Pretax Income
$ -71.27M$ -64.47M$ -37.69M$ -30.64M$ -31.67M
Net Income
$ -71.27M$ -64.47M$ -37.69M$ -30.64M$ -31.67M
Per Share Metrics
Basic EPS
$ -4.89$ -6.18$ -10.33$ -26.89$ -183.08
Diluted EPS
$ -4.89$ -6.18$ -10.33$ -26.89$ -183.08
Weighted Average Shares Outstanding
14.58M 10.44M 3.65M 1.14M 172.00K
Weighted Average Shares Outstanding (Diluted)
14.58M 10.44M 3.65M 1.14M 172.98K
Currency in USD

Jasper Therapeutics Earnings and Revenue History